Rectal bleeding after radiation therapy for prostate cancer: Endoscopic evaluation

Radiology

Volumn 217, Issue 1, 2000, Pages 215-218

  Moore, E M ^a   Magrino, T J ^a   Johnstone, P A S ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Prostate neoplasms, therapeutic radiology; Radiations, injurious effects, complications of therapeutic radiology; Rectum, abnormalities

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; ENDOSCOPY; EVALUATION; HEMATOCHEZIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE; RECTUM HEMORRHAGE; SIGMOID; SYMPTOMATOLOGY;

EID: 0034546311     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.217.1.r00oc24215     Document Type: Article

References (16)

1. Cancer statistics 1999
2. Global cancer statistics
3. Tolerance of the intestine to radiation therapy
4. Radiation proctitis: Therapy and prognosis
5. Proctitis after conventional external radiation therapy for prostate cancer: Importance of minimizing posterior rectal dose
6. Surgical treatment of radiation injuries of the colon and rectum
7. Endoscopic findings of the rectat mucosa after 3-D planned external irradiation of localized prostate cancer and their correlations with dose-volume-histograms
8. Colonoscopy in radiation colitis
9. Radiation-induced proctosigmoiditis
10. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient's perspective
11. Clinical course of rectal bleeding following 1-125 prostate brachy-therapy
12. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer
13. Late rectal bleeding following combined X-ray and proton high-dose irradiation for patients with stages T3-T4 prostate carcinoma
14. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy
15. Practice parameters for detection of colorectal neoplasms
16. Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year follow-up